GlassScriptPhysician profile
Jeffrey Paul Radabaugh
NPI 1073806378
$10,478.82
in general payments reported to CMS, 2019-2025
18 companies · $2,287 in 2025
The $2,287 reported for 2025 was more than what 91% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $414 · 2022: $2,198 · 2023: $4,574 · 2024: $1,007 · 2025: $2,287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,269 · Consulting Fee: $1,925 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,400 · Travel and Lodging: $1,240 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,268.76 |
| Consulting Fee | $1,925.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,400.00 |
| Travel and Lodging | $1,239.93 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,840.42 | 2021-2025 | Fusion, Nuvent, Propel |
| Integra Lifesciences Corporation | $1,436.31 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Regeneron Healthcare Solutions, INC. | $813.78 | 2021-2025 | Dupixent |
| Aerin Medical INC. | $645.83 | 2021-2025 | |
| Genzyme Corporation | $597.10 | 2021-2025 | |
| Neurent Medical Limited | $285.46 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Intersect Ent, INC. | $210.53 | 2022 | |
| Glaxosmithkline, LLC. | $191.84 | 2023-2024 | Nucala |
| Optinose US, INC. | $108.95 | 2021-2024 | |
| Amgen INC. | $78.96 | 2025 | Tezspire |
| Stryker Corporation | $72.80 | 2023-2025 | Audion Et Dilation System, Fiagon Navigation Unit |
| Inspire Medical Systems, INC. | $55.92 | 2023-2024 | Inspire |
| Access Pro Medical, LLC | $39.67 | 2023 | Matriderm |
| Olympus America INC. | $24.25 | 2025 | |
| Depuy Synthes Sales INC. | $23.62 | 2025 | Trumatch, Matrixmidface |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ars Pharmaceuticals Operations, INC. | $18.97 | 2025 | Neffy |
| Hologic Sales and Service, LLC | $18.21 | 2023 | Coolseal Generator |
| Alk-Abello, INC | $16.20 | 2025 | Ragwitek, Odactra, Grastek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Radabaugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.